首页 > 最新文献

American journal of medicine open最新文献

英文 中文
Improving Health Behaviors and Weight Parameters With Motivational Interviewing and the TEEEN Program in an Ethnically and Socioeconomically Diverse Pediatric Population. 在种族和社会经济多样化的儿科人群中,通过动机访谈和TEEEN®计划改善健康行为和体重参数
Pub Date : 2023-04-24 eCollection Date: 2023-12-01 DOI: 10.1016/j.ajmo.2023.100042
Jessica Castrillon Lal, Luba Margai, Helen Sarah Zitkovsky, Lori Lyn Price, Shirley González

Objective: Obesity affects 14.7 million children and adolescents in the United States. Children's health behaviors are affected by parental health practices. Therefore, pediatric obesity interventions should include parents. The objective of this study was to assess the changes in self-reported health behaviors in a diverse population attending the TEEEN program, with motivational interviewing of child-parent dyads as a key component, for 1 year.

Methods: Here we assessed the changes in Family and Nutrition and Physical Activity (FNPA) screening tool scores, a tool that assesses obesogenic behaviors, in the context of MI of child-parent dyads in a racially, ethnically, and socioeconomically diverse population who attended the TEEEN (Teens, Empowerment, Education, Exercise, Nutrition) program, a nonclinic and family-based behavior program in Massachusetts, for 1 year.

Results: Participation in the TEEEN program, which includes MI of child-parent dyads, was associated with a significant increase in the overall FNPA score (median change= 4 points, P = .007). We observed that 76.5% of children experienced a decrease in BMI% and BMI z-score. The change in BMI% (median= -0.9, P = .006) and change in BMI z-score (median= -0.2, P = .008) were statistically significant.

Conclusion: Participation in the TEEEN program seemed to be beneficial based on aspects of the FNPA screening tool and changes in weight parameters. The FNPA screening tool enhanced-motivational interviewing of child-parent dyads shows promise as an approach to address obesogenic behaviors. This study provides a detailed framework for medical providers to address pediatric obesity in a nonclinic setting with less time constraints.

目的:肥胖症影响着美国 1470 万儿童和青少年。儿童的健康行为受到父母健康行为的影响。因此,儿科肥胖症干预措施应包括家长。本研究的目的是评估参加 TEEEN 计划的不同人群在自我报告的健康行为方面的变化。方法:在马萨诸塞州参加了 TEEEN(青少年、赋权、教育、锻炼、营养)项目一年的种族、民族和社会经济多元化人群中,我们评估了家庭与营养和体育活动(FNPA)筛查工具得分的变化,该工具是一种评估肥胖行为的工具:参加 TEEEN 计划(包括对儿童和家长二人组进行多元智能教育)与 FNPA 总分的显著提高有关(中位数变化= 4 分,P = .007)。我们观察到,76.5% 的儿童的体重指数(BMI)% 和体重指数(BMI)z-分数有所下降。BMI% 的变化(中位数= -0.9,P = .006)和 BMI z-score 的变化(中位数= -0.2,P = .008)在统计学上有显著意义:从 FNPA 筛查工具和体重参数的变化来看,参与 TEEEN 计划似乎是有益的。FNPA筛查工具增强型儿童-家长二人组动机访谈有望成为解决肥胖行为的一种方法。这项研究为医疗服务提供者提供了一个详细的框架,使其能够在非诊所环境中,以较少的时间限制来解决小儿肥胖问题。
{"title":"Improving Health Behaviors and Weight Parameters With Motivational Interviewing and the TEEEN Program in an Ethnically and Socioeconomically Diverse Pediatric Population.","authors":"Jessica Castrillon Lal, Luba Margai, Helen Sarah Zitkovsky, Lori Lyn Price, Shirley González","doi":"10.1016/j.ajmo.2023.100042","DOIUrl":"10.1016/j.ajmo.2023.100042","url":null,"abstract":"<p><strong>Objective: </strong>Obesity affects 14.7 million children and adolescents in the United States. Children's health behaviors are affected by parental health practices. Therefore, pediatric obesity interventions should include parents. The objective of this study was to assess the changes in self-reported health behaviors in a diverse population attending the TEEEN program, with motivational interviewing of child-parent dyads as a key component, for 1 year.</p><p><strong>Methods: </strong>Here we assessed the changes in Family and Nutrition and Physical Activity (FNPA) screening tool scores, a tool that assesses obesogenic behaviors, in the context of MI of child-parent dyads in a racially, ethnically, and socioeconomically diverse population who attended the TEEEN (Teens, Empowerment, Education, Exercise, Nutrition) program, a nonclinic and family-based behavior program in Massachusetts, for 1 year.</p><p><strong>Results: </strong>Participation in the TEEEN program, which includes MI of child-parent dyads, was associated with a significant increase in the overall FNPA score (median change= 4 points, <i>P</i> = .007). We observed that 76.5% of children experienced a decrease in BMI% and BMI z-score. The change in BMI% (median= -0.9, <i>P</i> = .006) and change in BMI z-score (median= -0.2, <i>P</i> = .008) were statistically significant.</p><p><strong>Conclusion: </strong>Participation in the TEEEN program seemed to be beneficial based on aspects of the FNPA screening tool and changes in weight parameters. The FNPA screening tool enhanced-motivational interviewing of child-parent dyads shows promise as an approach to address obesogenic behaviors. This study provides a detailed framework for medical providers to address pediatric obesity in a nonclinic setting with less time constraints.</p>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11256232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42373709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Health Behaviors and Weight Parameters With Motivational Interviewing and the TEEEN Program in an Ethnically and Socioeconomically Diverse Pediatric Population 在种族和社会经济不同的儿科人群中,通过动机性访谈和青少年计划改善健康行为和体重参数
Pub Date : 2023-04-24 DOI: 10.1016/j.ajmo.2023.100042
Jessica Castrillon Lal , Luba Margai , Helen Sarah Zitkovsky , Lori Lyn Price , Shirley González , American Board of Obesity Medicine Diplomate

Objective

Obesity affects 14.7 million children and adolescents in the United States. Children's health behaviors are affected by parental health practices. Therefore, pediatric obesity interventions should include parents. The objective of this study was to assess the changes in self-reported health behaviors in a diverse population attending the TEEEN program, with motivational interviewing of child-parent dyads as a key component, for 1 year.

Methods

Here we assessed the changes in Family and Nutrition and Physical Activity (FNPA) screening tool scores, a tool that assesses obesogenic behaviors, in the context of MI of child-parent dyads in a racially, ethnically, and socioeconomically diverse population who attended the TEEEN (Teens, Empowerment, Education, Exercise, Nutrition) program, a nonclinic and family-based behavior program in Massachusetts, for 1 year.

Results

Participation in the TEEEN program, which includes MI of child-parent dyads, was associated with a significant increase in the overall FNPA score (median change= 4 points, P = .007). We observed that 76.5% of children experienced a decrease in BMI% and BMI z-score. The change in BMI% (median= −0.9, P = .006) and change in BMI z-score (median= −0.2, P = .008) were statistically significant.

Conclusion

Participation in the TEEEN program seemed to be beneficial based on aspects of the FNPA screening tool and changes in weight parameters. The FNPA screening tool enhanced-motivational interviewing of child-parent dyads shows promise as an approach to address obesogenic behaviors. This study provides a detailed framework for medical providers to address pediatric obesity in a nonclinic setting with less time constraints.

肥胖影响着美国1470万儿童和青少年。儿童的健康行为受到父母健康行为的影响。因此,儿童肥胖干预措施应包括父母。本研究的目的是评估参加TEEEN项目的不同人群自我报告的健康行为的变化,将儿童-父母二人组的动机访谈作为一个关键组成部分,为期1年。方法在这里,我们评估了在参加TEEEN(青少年、赋权、教育、锻炼、营养)项目的种族、民族和社会经济多样化人群中,在MI的背景下,家庭和营养与体育活动(FNPA)筛查工具得分的变化,FNPA是一种评估肥胖行为的工具,马萨诸塞州的一个非临床和基于家庭的行为项目,为期1年。结果参与TEEEN项目,包括儿童-父母二人组的MI,与总体FNPA评分的显著增加有关(中位数变化=4分,P=0.007)。我们观察到76.5%的儿童经历了BMI%和BMI z评分的下降。BMI%的变化(中位数=−0.9,P=.006)和BMI z评分的变化(中值=−0.2,P=.008)具有统计学意义。结论根据FNPA筛查工具和体重参数的变化,参与TEEEN项目似乎是有益的。FNPA筛查工具增强了儿童-父母二人组的动机访谈,有望成为解决肥胖行为的一种方法。这项研究为医疗提供者提供了一个详细的框架,以在时间限制较少的非临床环境中解决儿童肥胖问题。
{"title":"Improving Health Behaviors and Weight Parameters With Motivational Interviewing and the TEEEN Program in an Ethnically and Socioeconomically Diverse Pediatric Population","authors":"Jessica Castrillon Lal ,&nbsp;Luba Margai ,&nbsp;Helen Sarah Zitkovsky ,&nbsp;Lori Lyn Price ,&nbsp;Shirley González ,&nbsp;American Board of Obesity Medicine Diplomate","doi":"10.1016/j.ajmo.2023.100042","DOIUrl":"https://doi.org/10.1016/j.ajmo.2023.100042","url":null,"abstract":"<div><h3>Objective</h3><p>Obesity affects 14.7 million children and adolescents in the United States. Children's health behaviors are affected by parental health practices. Therefore, pediatric obesity interventions should include parents. The objective of this study was to assess the changes in self-reported health behaviors in a diverse population attending the TEEEN program, with motivational interviewing of child-parent dyads as a key component, for 1 year.</p></div><div><h3>Methods</h3><p>Here we assessed the changes in Family and Nutrition and Physical Activity (FNPA) screening tool scores, a tool that assesses obesogenic behaviors, in the context of MI of child-parent dyads in a racially, ethnically, and socioeconomically diverse population who attended the TEEEN (Teens, Empowerment, Education, Exercise, Nutrition) program, a nonclinic and family-based behavior program in Massachusetts, for 1 year.</p></div><div><h3>Results</h3><p>Participation in the TEEEN program, which includes MI of child-parent dyads, was associated with a significant increase in the overall FNPA score (median change= 4 points, <em>P</em> = .007). We observed that 76.5% of children experienced a decrease in BMI% and BMI z-score. The change in BMI% (median= −0.9, <em>P</em> = .006) and change in BMI z-score (median= −0.2, <em>P</em> = .008) were statistically significant.</p></div><div><h3>Conclusion</h3><p>Participation in the TEEEN program seemed to be beneficial based on aspects of the FNPA screening tool and changes in weight parameters. The FNPA screening tool enhanced-motivational interviewing of child-parent dyads shows promise as an approach to address obesogenic behaviors. This study provides a detailed framework for medical providers to address pediatric obesity in a nonclinic setting with less time constraints.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49734707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Clinical Burden of Idiopathic Dilated Cardiomyopathy in the United States 美国特发性扩张型心肌病的患病率和临床负担
Pub Date : 2023-02-25 DOI: 10.1016/j.ajmo.2023.100038
Yaa Ababio , Scott P. Kelly , Franca S Angeli , Joanne Berghout , Kui Huang , Kathy Liu , Sara Burns , Cynthia Senerchia , Rob Moccia , Gabriel C. Brooks

Background

Dilated cardiomyopathy (DCM) contributes significantly to heart failure prevalence, yet supporting epidemiologic data is sparse. This study sought to estimate the period prevalence of DCM and the proportion of idiopathic DCM in the United States using a large, diverse electronic health records (EHR) database.

Methods

This retrospective, observational study included 56,812,806 deidentified patients in Optum EHR with visits between 2017 and 2019. Suspected DCM cases were identified using ICD-10 coding. Deidentified clinical notes from 1000 randomly selected cases were manually reviewed to determine the diagnosis of DCM and estimate the proportion of idiopathic DCM. The period prevalence and clinical burden of DCM and idiopathic DCM were estimated.

Results

Manual clinical review demonstrated that our definition had a positive predictive value of 92.5% for DCM, with 46.3% estimated as the idiopathic DCM proportion. The estimated period prevalence of DCM between 2017 and 2019 was 118.33 per 100,000. Prevalence increased for adults ≥65 years of age, males, and African Americans. Extrapolation to the 2019 US population led to an overall estimated burden of roughly 388,350 patients. Adjusting for the proportion of cases with idiopathic DCM yielded an idiopathic DCM prevalence of 59.23 per 100,000 and a burden of 194,385 patients. Evidence of clinical genetic testing in this population was scarce, with less than 0.43% of DCM cases reporting a testing code.

Conclusions

This study establishes a conservative period prevalence for DCM and idiopathic DCM and demonstrates very low molecular genetic testing for DCM. These findings suggest that the clinical burden of genetic DCM may be underestimated.

背景扩张型心肌病(DCM)对心力衰竭的患病率有显著影响,但支持的流行病学数据很少。本研究试图使用一个大型、多样化的电子健康记录(EHR)数据库来估计美国扩张型心肌病的患病率和特发性扩张型心肌病比例。方法这项回顾性观察性研究纳入了2017年至2019年间就诊的56812806名Optum EHR确诊患者。使用ICD-10编码识别可疑DCM病例。从1000个随机选择的病例中手动回顾未识别的临床记录,以确定DCM的诊断并估计特发性DCM的比例。对扩张型心肌病和特发性扩张型心肌病的患病率和临床负担进行了评估。结果手动临床回顾表明,我们的定义对DCM的阳性预测值为92.5%,其中46.3%估计为特发性DCM比例。2017年至2019年间DCM的估计患病率为118.33/10万。≥65岁的成年人、男性和非裔美国人的患病率增加。根据2019年美国人口推断,总体估计负担约为388350名患者。调整特发性扩张型心肌病病例比例后,特发性DCM患病率为59.23/100000,患者负担为194385。在这一人群中进行临床基因检测的证据很少,只有不到0.43%的DCM病例报告了检测代码。结论本研究确定了DCM和特发性DCM的保守期患病率,并证明了DCM的低分子遗传检测。这些发现表明遗传性扩张型心肌病的临床负担可能被低估了。
{"title":"Prevalence and Clinical Burden of Idiopathic Dilated Cardiomyopathy in the United States","authors":"Yaa Ababio ,&nbsp;Scott P. Kelly ,&nbsp;Franca S Angeli ,&nbsp;Joanne Berghout ,&nbsp;Kui Huang ,&nbsp;Kathy Liu ,&nbsp;Sara Burns ,&nbsp;Cynthia Senerchia ,&nbsp;Rob Moccia ,&nbsp;Gabriel C. Brooks","doi":"10.1016/j.ajmo.2023.100038","DOIUrl":"https://doi.org/10.1016/j.ajmo.2023.100038","url":null,"abstract":"<div><h3>Background</h3><p>Dilated cardiomyopathy (DCM) contributes significantly to heart failure prevalence, yet supporting epidemiologic data is sparse. This study sought to estimate the period prevalence of DCM and the proportion of idiopathic DCM in the United States using a large, diverse electronic health records (EHR) database.</p></div><div><h3>Methods</h3><p>This retrospective, observational study included 56,812,806 deidentified patients in Optum EHR with visits between 2017 and 2019. Suspected DCM cases were identified using ICD-10 coding. Deidentified clinical notes from 1000 randomly selected cases were manually reviewed to determine the diagnosis of DCM and estimate the proportion of idiopathic DCM. The period prevalence and clinical burden of DCM and idiopathic DCM were estimated.</p></div><div><h3>Results</h3><p>Manual clinical review demonstrated that our definition had a positive predictive value of 92.5% for DCM, with 46.3% estimated as the idiopathic DCM proportion. The estimated period prevalence of DCM between 2017 and 2019 was 118.33 per 100,000. Prevalence increased for adults ≥65 years of age, males, and African Americans. Extrapolation to the 2019 US population led to an overall estimated burden of roughly 388,350 patients. Adjusting for the proportion of cases with idiopathic DCM yielded an idiopathic DCM prevalence of 59.23 per 100,000 and a burden of 194,385 patients. Evidence of clinical genetic testing in this population was scarce, with less than 0.43% of DCM cases reporting a testing code.</p></div><div><h3>Conclusions</h3><p>This study establishes a conservative period prevalence for DCM and idiopathic DCM and demonstrates very low molecular genetic testing for DCM. These findings suggest that the clinical burden of genetic DCM may be underestimated.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49734708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PCSK9 Inhibitor Use and Outcomes Using Concomitant Lipid-Lowering Therapies in the Veterans Health Administration. 退伍军人健康管理局PCSK9抑制剂的使用和伴随降脂治疗的结果
Pub Date : 2023-02-18 eCollection Date: 2023-06-01 DOI: 10.1016/j.ajmo.2023.100035
Jessica Eloso, Asma Awad, Xinhua Zhao, Francesca E Cunningham, Rongping Zhang, Diane Dong, Cathy Kelley, Peter A Glassman, Sherrie L Aspinall

Background: Real-world data on use of PCSK9 inhibitors (PCSK9-Is), with or without statins and/or ezetimibe, and associated outcomes, can inform more effective prescribing. The objective was to evaluate clinical effectiveness and safety of PCSK9-Is within the Veterans Health Administration (VHA).

Methods: In this retrospective cohort study, we included Veterans who had at least one outpatient prescription for alirocumab and/or evolocumab filled within VHA between August 21, 2015, and September 30, 2020. Analyses included 4 mutually exclusive subgroups: PCSK9-I alone, PCSK9-I+statin, PCSK9-I+ezetimibe, and PCSK9-I+statin+ezetimibe subgroups. Primary outcomes included medication possession ratio, persistence, and low-density lipoprotein (LDL).

Results: Among Veterans in the analytical cohort (n = 2428), 36.2% were on PCSK9-I monotherapy; 24.0% received a PCSK9-I+statin; 27.4% were on a PCSK9-I+ezetimibe; and 12.4% received triple therapy, that is, PCSK9-I+statin+ezetimibe. The mean medication possession ratio (standard deviation [SD]) for PCSK9-I monotherapy was 83.8% (13.3) compared to 84.3% (11.2) with PCSK9-I+statin therapy, 87.1% (10.1) with PCSK9-I+ezetimibe therapy, and 85.8% (11.7) with triple therapy. The percentage of patients who discontinued PCSK9-I in the monotherapy subgroup was 12.3% vs 9.5%, 6.6%, and 7.4% in the concomitant statin, ezetimibe, and triple-therapy subgroups, respectively (p = .002 among the groups). Mean LDL level was greater in the PCSK9-I monotherapy subgroup (85.6 mg/dL) compared with the concomitant statin (66.5 mg/dL), ezetimibe (65.7 mg/dL), and triple-therapy subgroups (68.1 mg/dL).

Conclusions: Veterans showed good adherence and/or persistence with PCSK9-I regimens. On average, those receiving concomitant therapy with a statin and/or ezetimibe achieved significantly lower LDL levels.

背景:有关 PCSK9 抑制剂(PCSK9-Is)与他汀类药物和/或依折麦布的使用情况及相关结果的真实世界数据可为更有效地开具处方提供依据。目的是评估退伍军人健康管理局(VHA)中 PCSK9-Is 的临床有效性和安全性:在这项回顾性队列研究中,我们纳入了在 2015 年 8 月 21 日至 2020 年 9 月 30 日期间在退伍军人健康管理局(VHA)内至少开具过一次阿利珠单抗和/或 evolocumab 门诊处方的退伍军人。分析包括 4 个相互排斥的亚组:单用 PCSK9-I、PCSK9-I+司他汀、PCSK9-I+依泽替米贝和 PCSK9-I+ 司他汀+依泽替米贝亚组。主要结果包括药物占有率、持续率和低密度脂蛋白(LDL):在分析队列中的退伍军人(n = 2428)中,36.2%接受PCSK9-I单药治疗;24.0%接受PCSK9-I+司他汀;27.4%接受PCSK9-I+依泽替米布;12.4%接受三联疗法,即PCSK9-I+司他汀+依泽替米布。PCSK9-I单一疗法的平均药物持有率(标准差[SD])为83.8%(13.3),而PCSK9-I+他汀疗法为84.3%(11.2),PCSK9-I+依泽替米贝疗法为87.1%(10.1),三联疗法为85.8%(11.7)。单药治疗亚组中停用 PCSK9-I 的患者比例为 12.3%,而他汀类药物、依泽替米贝和三联疗法同时使用亚组中停用 PCSK9-I 的患者比例分别为 9.5%、6.6% 和 7.4%(各组间 p = 0.002)。PCSK9-I单药治疗亚组的平均低密度脂蛋白水平(85.6 mg/dL)高于同时服用他汀类药物亚组(66.5 mg/dL)、依折麦布亚组(65.7 mg/dL)和三联疗法亚组(68.1 mg/dL):退伍军人对 PCSK9-I 治疗方案的依从性和/或持久性良好。平均而言,同时接受他汀类药物和/或依折麦布治疗的退伍军人的低密度脂蛋白水平明显降低。
{"title":"PCSK9 Inhibitor Use and Outcomes Using Concomitant Lipid-Lowering Therapies in the Veterans Health Administration.","authors":"Jessica Eloso, Asma Awad, Xinhua Zhao, Francesca E Cunningham, Rongping Zhang, Diane Dong, Cathy Kelley, Peter A Glassman, Sherrie L Aspinall","doi":"10.1016/j.ajmo.2023.100035","DOIUrl":"10.1016/j.ajmo.2023.100035","url":null,"abstract":"<p><strong>Background: </strong>Real-world data on use of PCSK9 inhibitors (PCSK9-Is), with or without statins and/or ezetimibe, and associated outcomes, can inform more effective prescribing. The objective was to evaluate clinical effectiveness and safety of PCSK9-Is within the Veterans Health Administration (VHA).</p><p><strong>Methods: </strong>In this retrospective cohort study, we included Veterans who had at least one outpatient prescription for alirocumab and/or evolocumab filled within VHA between August 21, 2015, and September 30, 2020. Analyses included 4 mutually exclusive subgroups: PCSK9-I alone, PCSK9-I+statin, PCSK9-I+ezetimibe, and PCSK9-I+statin+ezetimibe subgroups. Primary outcomes included medication possession ratio, persistence, and low-density lipoprotein (LDL).</p><p><strong>Results: </strong>Among Veterans in the analytical cohort (<i>n</i> = 2428), 36.2% were on PCSK9-I monotherapy; 24.0% received a PCSK9-I+statin; 27.4% were on a PCSK9-I+ezetimibe; and 12.4% received triple therapy, that is, PCSK9-I+statin+ezetimibe. The mean medication possession ratio (standard deviation [SD]) for PCSK9-I monotherapy was 83.8% (13.3) compared to 84.3% (11.2) with PCSK9-I+statin therapy, 87.1% (10.1) with PCSK9-I+ezetimibe therapy, and 85.8% (11.7) with triple therapy. The percentage of patients who discontinued PCSK9-I in the monotherapy subgroup was 12.3% vs 9.5%, 6.6%, and 7.4% in the concomitant statin, ezetimibe, and triple-therapy subgroups, respectively (<i>p</i> = .002 among the groups). Mean LDL level was greater in the PCSK9-I monotherapy subgroup (85.6 mg/dL) compared with the concomitant statin (66.5 mg/dL), ezetimibe (65.7 mg/dL), and triple-therapy subgroups (68.1 mg/dL).</p><p><strong>Conclusions: </strong>Veterans showed good adherence and/or persistence with PCSK9-I regimens. On average, those receiving concomitant therapy with a statin and/or ezetimibe achieved significantly lower LDL levels.</p>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11256282/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49482490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's response 作者的回应
Pub Date : 2022-12-01 DOI: 10.1016/j.ajmo.2022.100018
Dayawa D. Agoons , Batakeh B. Agoons , Kelechi E. Emmanuel , Firdausi A. Matawalle , Jessica M. Cunningham
{"title":"Author's response","authors":"Dayawa D. Agoons ,&nbsp;Batakeh B. Agoons ,&nbsp;Kelechi E. Emmanuel ,&nbsp;Firdausi A. Matawalle ,&nbsp;Jessica M. Cunningham","doi":"10.1016/j.ajmo.2022.100018","DOIUrl":"https://doi.org/10.1016/j.ajmo.2022.100018","url":null,"abstract":"","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667036422000127/pdfft?md5=b99c07c227a3565a3e8b2131e88fcf3f&pid=1-s2.0-S2667036422000127-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136884685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender inequality for tenure as Full Professor of medicine in France 法国医学正教授终身职位的性别不平等
Pub Date : 2022-12-01 DOI: 10.1016/j.ajmo.2022.100024
Sophie Ziai , Florian Naudet , Bruno Laviolle , Jean-Sébastien Allain

Introduction

Under-representation of women in high academic and medical positions is reported in many countries. This study aims to compare degrees and careers between men and women tenured as Full Professors of Medicine in recent years in France.

Methods

We identified all new tenured French Full Professors between 2017 and 2021 and collected the publicly available data (gender, year of birth, curriculum) from the Bibliographic Agency for Higher Education, a public institution under the aegis of the Ministry for Higher Education Research and Innovation. The primary outcome was the gender difference in age appointment of Full Professors. Secondary outcomes were gender differences in career development.

Results

Among 820 Full Professors, only 266 (32.4%) were women. They were tenured at a later age than men (43.7 vs 42.4 years, p<0.001), while they graduated for the MD (29.5 vs 29.9 years, p<0.005) or PhD (35.3 vs 36.0 years, p<0.05) several months earlier. Women were also more often Associate Professors than men before becoming Full Professors (67.3% vs 59.2%, p<0.05).  Before achieving Full professor tenure, the average delay is longer for women from MD graduation (14.6 vs 12.5 years), PhD graduation (8.7 vs 6.4 years), or Associate Professor nomination (7.5 vs 5.5 years), with a difference of 2.2, 2.4 and 2.0 years respectively (p<0.001 for all comparisons).

Conclusion

Gender inequalities remain in regards to access to Full Professor status, the highest position in the medical fields.

导言据报道,在许多国家,妇女在高级学术和医疗职位上的代表性不足。这项研究旨在比较近年来法国男性和女性医学全职教授的学位和职业。方法:我们确定了2017年至2021年间所有新的法国终身教授,并从高等教育文献局(高等教育研究与创新部下属的公共机构)收集了公开可用的数据(性别、出生年份、课程)。主要结果是全职教授在年龄上的性别差异。次要结果是职业发展的性别差异。结果在820名正教授中,女性只有266人(32.4%)。她们获得终身职位的年龄比男性晚(43.7年对42.4年,p < 0.001),而她们获得医学博士学位(29.5年对29.9年,p < 0.001)或博士学位(35.3年对36.0年,p < 0.05)的时间比男性早几个月。在成为正教授之前,女性也比男性更多地成为副教授(67.3% vs 59.2%, p<0.05)。在获得正教授任期之前,女性从医学博士毕业(14.6年对12.5年)、博士毕业(8.7年对6.4年)或副教授提名(7.5年对5.5年)获得职位的平均延迟时间更长,差异分别为2.2年、2.4年和2.0年(所有比较的差异为0.001)。结论在获得医学领域最高职位——正教授地位方面,性别不平等现象仍然存在。
{"title":"Gender inequality for tenure as Full Professor of medicine in France","authors":"Sophie Ziai ,&nbsp;Florian Naudet ,&nbsp;Bruno Laviolle ,&nbsp;Jean-Sébastien Allain","doi":"10.1016/j.ajmo.2022.100024","DOIUrl":"10.1016/j.ajmo.2022.100024","url":null,"abstract":"<div><h3>Introduction</h3><p>Under-representation of women in high academic and medical positions is reported in many countries. This study aims to compare degrees and careers between men and women tenured as Full Professors of Medicine in recent years in France.</p></div><div><h3>Methods</h3><p>We identified all new tenured French Full Professors between 2017 and 2021 and collected the publicly available data (gender, year of birth, curriculum) from the Bibliographic Agency for Higher Education, a public institution under the aegis of the Ministry for Higher Education Research and Innovation. The primary outcome was the gender difference in age appointment of Full Professors. Secondary outcomes were gender differences in career development.</p></div><div><h3>Results</h3><p>Among 820 Full Professors, only 266 (32.4%) were women. They were tenured at a later age than men (43.7 vs 42.4 years, p&lt;0.001), while they graduated for the MD (29.5 vs 29.9 years, p&lt;0.005) or PhD (35.3 vs 36.0 years, p&lt;0.05) several months earlier. Women were also more often Associate Professors than men before becoming Full Professors (67.3% vs 59.2%, p&lt;0.05).  Before achieving Full professor tenure, the average delay is longer for women from MD graduation (14.6 vs 12.5 years), PhD graduation (8.7 vs 6.4 years), or Associate Professor nomination (7.5 vs 5.5 years), with a difference of 2.2, 2.4 and 2.0 years respectively (p&lt;0.001 for all comparisons).</p></div><div><h3>Conclusion</h3><p>Gender inequalities remain in regards to access to Full Professor status, the highest position in the medical fields.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266703642200019X/pdfft?md5=d8e476e2f836219434afcda66baf572c&pid=1-s2.0-S266703642200019X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45007099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A realist process evaluation of the INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) randomized controlled trial in India 印度抑郁症和糖尿病联合治疗(独立)随机对照试验的现实过程评价
Pub Date : 2022-12-01 DOI: 10.1016/j.ajmo.2022.100015
Leslie C.M. Johnson , Nancy J. Thompson , Mohammed K. Ali , Kirk Elifson , Lydia Chwastiak , Viswanathan Mohan , Ranjit Mohan Anjana , Subramani Poongothai , Nikhil Tandon

Aims

We aimed to determine what key resources, mechanisms, and contextual factors are necessary to integrate depression and diabetes treatment into low-resource settings.

Methods

A realist evaluation framework was employed to conduct a comparative case study. Data were collected through document review, key informant interviews (n=4), activity logs, and interviews with implementing health care providers (n=11) to test and refine program theories for collaborative care.

Results

Efforts to enhance patient care coordination (i.e., adapting clinics’ patient flow and resources, on-going trainings, and on-site support for care coordinators) improved implementation of depression treatment by usual care diabetes physicians. Clinician's avoidance of the term depression was identified as a barrier to mental health counseling and treatment.

Conclusions

The variations in organizational features and processes linked to implementation activities across two clinics provided an opportunity to examine how and why different contextual factors help or hinder the implementation process. Findings from this study demonstrate that successful implementation of an integrated depression and diabetes care model is feasible in a low-resource setting, while the revised program theories provide an explanatory framework of coordinated care implementation processes that can inform future efforts to disseminate and scale this care model.

目的:我们旨在确定在低资源环境中整合抑郁症和糖尿病治疗所需的关键资源、机制和环境因素。方法采用现实主义评价框架进行案例对比研究。通过文献回顾、关键信息提供者访谈(n=4)、活动日志和对实施卫生保健提供者的访谈(n=11)收集数据,以检验和完善协作护理的程序理论。结果加强患者护理协调(如适应诊所的患者流量和资源、持续培训和对护理协调员的现场支持)改善了常规护理糖尿病医生对抑郁症治疗的实施。临床医生对“抑郁”一词的回避被认为是心理健康咨询和治疗的障碍。结论:两个诊所的组织特征和流程的差异与实施活动有关,这为研究不同的背景因素如何以及为什么有助于或阻碍实施过程提供了机会。本研究的结果表明,在低资源环境下,成功实施抑郁症和糖尿病综合护理模式是可行的,而修订后的项目理论为协调护理实施过程提供了一个解释框架,可以为未来推广和扩大这种护理模式提供信息。
{"title":"A realist process evaluation of the INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) randomized controlled trial in India","authors":"Leslie C.M. Johnson ,&nbsp;Nancy J. Thompson ,&nbsp;Mohammed K. Ali ,&nbsp;Kirk Elifson ,&nbsp;Lydia Chwastiak ,&nbsp;Viswanathan Mohan ,&nbsp;Ranjit Mohan Anjana ,&nbsp;Subramani Poongothai ,&nbsp;Nikhil Tandon","doi":"10.1016/j.ajmo.2022.100015","DOIUrl":"10.1016/j.ajmo.2022.100015","url":null,"abstract":"<div><h3>Aims</h3><p>We aimed to determine what key resources, mechanisms, and contextual factors are necessary to integrate depression and diabetes treatment into low-resource settings.</p></div><div><h3>Methods</h3><p>A realist evaluation framework was employed to conduct a comparative case study. Data were collected through document review, key informant interviews (<em>n</em>=4), activity logs, and interviews with implementing health care providers (n=11) to test and refine program theories for collaborative care.</p></div><div><h3>Results</h3><p>Efforts to enhance patient care coordination (i.e., adapting clinics’ patient flow and resources, on-going trainings, and on-site support for care coordinators) improved implementation of depression treatment by usual care diabetes physicians. Clinician's avoidance of the term depression was identified as a barrier to mental health counseling and treatment.</p></div><div><h3>Conclusions</h3><p>The variations in organizational features and processes linked to implementation activities across two clinics provided an opportunity to examine how and why different contextual factors help or hinder the implementation process. Findings from this study demonstrate that successful implementation of an integrated depression and diabetes care model is feasible in a low-resource setting, while the revised program theories provide an explanatory framework of coordinated care implementation processes that can inform future efforts to disseminate and scale this care model.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ea/f0/nihms-1858340.PMC9788650.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10506006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corticosteroid administration and glycemic outcomes during treatment of acute exacerbation of chronic obstructive pulmonary disease 慢性阻塞性肺疾病急性加重期治疗期间皮质类固醇给药与血糖结局
Pub Date : 2022-12-01 DOI: 10.1016/j.ajmo.2022.100027
Herman Joseph Johannesmeyer , Kayvan Moussavi , Kerry Anne Rambaran , Kristica Kolyouthapong

Background

While international guidelines recommend low doses of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) clinical practice patterns show significant heterogeneity. Increasing doses of corticosteroids have inconsistently been associated with a greater risk of hyperglycemia.

Methods

Patients admitted to inpatient services for AECOPD were retrospectively enrolled. Hospitalization corticosteroid doses, daily blood glucose levels, and other markers of corticosteroid excess were collected. Correlative and regression analyses were conducted to assess the relationship between corticosteroid dose and average hospitalization blood glucose.

Results

Daily corticosteroid dose significantly predicted a higher blood glucose (rs=0.179, p=0.0095; p<0.0028 respectively) and cumulative corticosteroid dose predicted a longer hospital length of stay in bivariate and multivariate analyses (rs=0.679, p<0.0001; p<0.0001 respectively). Patients that experienced hypernatremia, hypokalemia, acute hyperglycemia, and acute hypertension received larger corticosteroid doses than patients that did not experience these complicating events.

Conclusions

We identified that increasing amounts of corticosteroids administered to inpatients experiencing AECOPD experienced higher average hospitalization blood glucose values, protracted hospitalizations, and other untoward effects.

背景:虽然国际指南推荐低剂量全身性皮质类固醇治疗慢性阻塞性肺疾病急性加重(AECOPD),但临床实践模式显示出显著的异质性。皮质类固醇剂量的增加与高血糖风险的增加有不一致的关系。方法回顾性纳入住院治疗AECOPD的患者。收集住院皮质类固醇剂量、每日血糖水平和其他皮质类固醇过量的标志物。通过相关分析和回归分析来评估皮质类固醇剂量与平均住院血糖的关系。结果每日皮质类固醇剂量与血糖升高有显著相关性(rs=0.179, p=0.0095;在双变量和多变量分析中,累积皮质类固醇剂量预测更长的住院时间(rs=0.679, P<0.0001;术;0.0001分别)。出现高钠血症、低钾血症、急性高血糖和急性高血压的患者比没有出现这些并发症的患者接受更大的皮质类固醇剂量。结论:我们发现,对AECOPD住院患者使用糖皮质激素的剂量增加会导致平均住院血糖值升高、住院时间延长和其他不良反应。
{"title":"Corticosteroid administration and glycemic outcomes during treatment of acute exacerbation of chronic obstructive pulmonary disease","authors":"Herman Joseph Johannesmeyer ,&nbsp;Kayvan Moussavi ,&nbsp;Kerry Anne Rambaran ,&nbsp;Kristica Kolyouthapong","doi":"10.1016/j.ajmo.2022.100027","DOIUrl":"10.1016/j.ajmo.2022.100027","url":null,"abstract":"<div><h3>Background</h3><p>While international guidelines recommend low doses of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) clinical practice patterns show significant heterogeneity. Increasing doses of corticosteroids have inconsistently been associated with a greater risk of hyperglycemia.</p></div><div><h3>Methods</h3><p>Patients admitted to inpatient services for AECOPD were retrospectively enrolled. Hospitalization corticosteroid doses, daily blood glucose levels, and other markers of corticosteroid excess were collected. Correlative and regression analyses were conducted to assess the relationship between corticosteroid dose and average hospitalization blood glucose.</p></div><div><h3>Results</h3><p>Daily corticosteroid dose significantly predicted a higher blood glucose (rs=0.179, p=0.0095; p&lt;0.0028 respectively) and cumulative corticosteroid dose predicted a longer hospital length of stay in bivariate and multivariate analyses (rs=0.679, p&lt;0.0001; p&lt;0.0001 respectively). Patients that experienced hypernatremia, hypokalemia, acute hyperglycemia, and acute hypertension received larger corticosteroid doses than patients that did not experience these complicating events.</p></div><div><h3>Conclusions</h3><p>We identified that increasing amounts of corticosteroids administered to inpatients experiencing AECOPD experienced higher average hospitalization blood glucose values, protracted hospitalizations, and other untoward effects.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266703642200022X/pdfft?md5=641ab8f5fbbe02e6d7309c7b3fa65326&pid=1-s2.0-S266703642200022X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46002353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trauma-related acute kidney injury during inpatient care of femoral fractures increases the risk of mortality: A claims data analysis 股骨骨折住院治疗期间创伤性急性肾损伤增加死亡风险:索赔数据分析
Pub Date : 2022-12-01 DOI: 10.1016/j.ajmo.2022.100009
Gisela Büchele , Martin Rehm , Rebecca Halbgebauer , Dietrich Rothenbacher , Markus Huber-Lang

Objectives: Although femoral fractures can hit anyone, they carry an especially high burden in the elderly and are multifaceted in their injury pattern, related complications, and subsequent therapeutic strategies. An often underestimated posttraumatic risk is the development of trauma-related acute kidney injury (TRAKI). However, for TRAKI, no outcome study with a large data approach exists addressing fractures. Therefore, we analyzed the development of TRAKI in regard to different covariates and quantified the association of TRAKI with overall mortality.

Design: Retrospective cohort study with claims data.

Setting and participants: 119,000 patients from Germany with femur fracture.

Methods: We calculated cumulative mortality, mortality rates per 100 person-years (both occurring within 180 days after fracture), and adjusted hazard ratios with 95%-confidence intervals (CI).

Results: Patients with femur shaft fractures showed an incidence of 6.1% for TRAKI, followed by patients with femur neck fractures with an incidence of 5.7%, and by patients with distal fractures with an incidence of 4.5%, respectively. Overall, in patients with any femur fracture, we found a 3.17-times higher mortality rate (95%-CI: 3.02-3.26) during 180 days of observation in patients who developed TRAKI in comparison to patients without. The risk for development of TRAKI was significantly increased with increasing TRAKI stage, age, and time until surgical intervention.

Conclusions and implications: In conclusion, patients suffering from proximal-, shaft-, and distal femoral fracture face an over 3-times higher 180 day-mortality rate in case of posttraumatic TRAKI, which should be considered in peri-traumatic care to improve the long-term outcome of these patients.

目的:尽管任何人都可能发生股骨骨折,但老年人的负担尤其重,而且其损伤模式、相关并发症和随后的治疗策略都是多方面的。一个经常被低估的创伤后风险是创伤性急性肾损伤(TRAKI)的发展。然而,对于TRAKI,目前还没有针对骨折的大数据结果研究。因此,我们根据不同的协变量分析了TRAKI的发展,并量化了TRAKI与总死亡率的关系。设计:回顾性队列研究与索赔数据。背景和参与者:119,000名来自德国的股骨骨折患者。方法:我们计算了累积死亡率、每100人年死亡率(均发生在骨折后180天内),并以95%置信区间(CI)调整了风险比。结果:股骨骨干骨折患者的TRAKI发生率为6.1%,股骨颈骨折患者的TRAKI发生率为5.7%,股骨远端骨折患者的TRAKI发生率为4.5%。总的来说,在任何股骨骨折的患者中,我们发现在180天的观察中,发生TRAKI的患者的死亡率比没有发生TRAKI的患者高3.17倍(95% ci: 3.02-3.26)。发生TRAKI的风险随着TRAKI分期、年龄和手术前时间的增加而显著增加。结论和意义:总之,股骨近端、股骨骨干和股骨远端骨折的患者在创伤后TRAKI的180天死亡率要高出3倍以上,在创伤后护理中应考虑到这一点,以改善这些患者的长期预后。
{"title":"Trauma-related acute kidney injury during inpatient care of femoral fractures increases the risk of mortality: A claims data analysis","authors":"Gisela Büchele ,&nbsp;Martin Rehm ,&nbsp;Rebecca Halbgebauer ,&nbsp;Dietrich Rothenbacher ,&nbsp;Markus Huber-Lang","doi":"10.1016/j.ajmo.2022.100009","DOIUrl":"10.1016/j.ajmo.2022.100009","url":null,"abstract":"<div><p><em>Objectives:</em> Although femoral fractures can hit anyone, they carry an especially high burden in the elderly and are multifaceted in their injury pattern, related complications, and subsequent therapeutic strategies. An often underestimated posttraumatic risk is the development of trauma-related acute kidney injury (TRAKI). However, for TRAKI, no outcome study with a large data approach exists addressing fractures. Therefore, we analyzed the development of TRAKI in regard to different covariates and quantified the association of TRAKI with overall mortality.</p><p><em>Design:</em> Retrospective cohort study with claims data.</p><p><em>Setting and participants:</em> 119,000 patients from Germany with femur fracture.</p><p><em>Methods:</em> We calculated cumulative mortality, mortality rates per 100 person-years (both occurring within 180 days after fracture), and adjusted hazard ratios with 95%-confidence intervals (CI).</p><p><em>Results:</em> Patients with femur shaft fractures showed an incidence of 6.1% for TRAKI, followed by patients with femur neck fractures with an incidence of 5.7%, and by patients with distal fractures with an incidence of 4.5%, respectively. Overall, in patients with any femur fracture, we found a 3.17-times higher mortality rate (95%-CI: 3.02-3.26) during 180 days of observation in patients who developed TRAKI in comparison to patients without. The risk for development of TRAKI was significantly increased with increasing TRAKI stage, age, and time until surgical intervention.</p><p><em>Conclusions and implications:</em> In conclusion, patients suffering from proximal-, shaft-, and distal femoral fracture face an over 3-times higher 180 day-mortality rate in case of posttraumatic TRAKI, which should be considered in peri-traumatic care to improve the long-term outcome of these patients.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667036422000048/pdfft?md5=d0da7aa8145eec79a6caf108bfbdc864&pid=1-s2.0-S2667036422000048-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45733828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Medicaid insured persons with diabetes have increased proportion of missed appointments and high HbA1c 医疗补助参保的糖尿病患者错过预约和高糖化血红蛋白的比例增加
Pub Date : 2022-12-01 DOI: 10.1016/j.ajmo.2022.100022
Ramya Radhakrishnan, William Cade, Ernesto Bernal-Mizrachi, Rajesh Garg

Objective

This study was conducted to evaluate whether the type of insurance coverage is associated with missed appointments and to evaluate the effect of missed appointments on diabetes control.

Methods

All patients with diabetes mellitus (DM) managed at a major academic medical center between Jan 2015 and Dec 2020 were included in analysis. Association between insurance coverage and the proportion of missed appointments was evaluated with adjustments for demographic variables and social determinants of health. The relationship between proportion of missed appointments and glycemic control was also evaluated.

Results

The dataset included 30,633 patients, out of which 14,064 (46%) reported commercial insurance, 13,376 (44%) reported Medicare and 3,193 (10%) reported Medicaid coverage. Proportion of missed appointments was 18.1 ± 18.1% among Medicaid covered patients,12.1 ± 15.3% among commercially insured and 10.2 ± 14.1% among Medicare covered patients (p < 0.001). Type of insurance was found to be a significant predictor of proportion of missed appointments after adjusting for age, race, language, marital status, smoking, BMI, HbA1c and type of diabetes (p < 0.001) in series regression analysis. Proportion of missed appointments was associated with HbA1c with partial correlation coefficient +0.104 (p < 0.005) after adjusting for age, race, gender, type of insurance coverage, BMI and type of diabetes.

Conclusions

Medicaid covered patients with diabetes have higher proportion of missed clinic appointments and higher HbA1c. More research is needed to evaluate the root causes of inability to keep appointments in this population so that strategies for improved healthcare delivery can be designed.

目的本研究旨在评估保险覆盖类型是否与错过预约有关,并评估错过预约对糖尿病控制的影响。方法选取2015年1月至2020年12月在某大型学术医疗中心就诊的所有糖尿病(DM)患者。通过调整人口统计变量和健康的社会决定因素,评估了保险覆盖率与错过预约比例之间的关系。还评估了失诊比例与血糖控制之间的关系。结果该数据集包括30,633名患者,其中14,064名(46%)报告了商业保险,13,376名(44%)报告了医疗保险,3,193名(10%)报告了医疗补助。医疗补助参保患者预约失约比例为18.1±18.1%,商业参保患者为12.1±15.3%,医疗保险参保患者为10.2±14.1% (p <0.001)。在调整年龄、种族、语言、婚姻状况、吸烟、BMI、HbA1c和糖尿病类型后,发现保险类型是错过预约比例的重要预测因子(p <0.001)。漏诊比例与HbA1c相关,偏相关系数为+0.104 (p <0.005),在调整了年龄、种族、性别、保险范围类型、BMI和糖尿病类型后。结论医疗补助覆盖的糖尿病患者有较高的错过门诊比例和较高的HbA1c。需要更多的研究来评估这一人群无法按时就诊的根本原因,以便设计出改善医疗保健服务的策略。
{"title":"Medicaid insured persons with diabetes have increased proportion of missed appointments and high HbA1c","authors":"Ramya Radhakrishnan,&nbsp;William Cade,&nbsp;Ernesto Bernal-Mizrachi,&nbsp;Rajesh Garg","doi":"10.1016/j.ajmo.2022.100022","DOIUrl":"https://doi.org/10.1016/j.ajmo.2022.100022","url":null,"abstract":"<div><h3>Objective</h3><p>This study was conducted to evaluate whether the type of insurance coverage is associated with missed appointments and to evaluate the effect of missed appointments on diabetes control.</p></div><div><h3>Methods</h3><p>All patients with diabetes mellitus (DM) managed at a major academic medical center between Jan 2015 and Dec 2020 were included in analysis. Association between insurance coverage and the proportion of missed appointments was evaluated with adjustments for demographic variables and social determinants of health. The relationship between proportion of missed appointments and glycemic control was also evaluated.</p></div><div><h3>Results</h3><p>The dataset included 30,633 patients, out of which 14,064 (46%) reported commercial insurance, 13,376 (44%) reported Medicare and 3,193 (10%) reported Medicaid coverage. Proportion of missed appointments was 18.1 ± 18.1% among Medicaid covered patients,12.1 ± 15.3% among commercially insured and 10.2 ± 14.1% among Medicare covered patients (<em>p</em> &lt; 0.001). Type of insurance was found to be a significant predictor of proportion of missed appointments after adjusting for age, race, language, marital status, smoking, BMI, HbA1c and type of diabetes (<em>p</em> &lt; 0.001) in series regression analysis. Proportion of missed appointments was associated with HbA1c with partial correlation coefficient +0.104 (<em>p</em> &lt; 0.005) after adjusting for age, race, gender, type of insurance coverage, BMI and type of diabetes.</p></div><div><h3>Conclusions</h3><p>Medicaid covered patients with diabetes have higher proportion of missed clinic appointments and higher HbA1c. More research is needed to evaluate the root causes of inability to keep appointments in this population so that strategies for improved healthcare delivery can be designed.</p></div>","PeriodicalId":72168,"journal":{"name":"American journal of medicine open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667036422000176/pdfft?md5=29838a781a5056f0325313cef8d2fc2a&pid=1-s2.0-S2667036422000176-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136885551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of medicine open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1